Metabolic cell death in cancer: ferroptosis, cuproptosis, disulfidptosis, and beyond

Abstract

Cell death resistance represents a hallmark of cancer. Recent studies have identified metabolic cell death as unique forms of regulated cell death resulting from an imbalance in the cellular metabolism. This review discusses the mechanisms of metabolic cell death—ferroptosis, cuproptosis, disulfidptosis, lysozincrosis, and alkaliptosis—and explores their potential in cancer therapy. Our review underscores the complexity of the metabolic cell death pathways and offers insights into innovative therapeutic avenues for cancer treatment.

Keywords

cell death / cancer treatment / ferroptosis / cuproptosis / disulfidptosis

References

[1] AlborziniaH, FlorezAF, KrethS et al. MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis. Nat Cancer 2022;3:471–485.

[2] AlborziniaH, ChenZ, YildizU et al. LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma. EMBO Mol Med 2023;15:e18014.

[3] AlimI, Caulfield JT, ChenY et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell 2019;177:1262–1279.e25.

[4] BadgleyMA, KremerDM, MaurerHC et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science 2020;368:85–89.

[5] BannaiS. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem 1986;261:2256–2263.

[6] BedouiS, HeroldMJ, StrasserA. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol 2020;21:678–695.

[7] BersukerK, Hendricks JM, LiZ et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 2019;575:688–692.

[8] BrownCW, AmanteJJ, ChhoyP et al. Prominin2 drives ferroptosis resistance by stimulating iron export. Dev Cell 2019;51:575–586.e4.

[9] CarneiroBA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 2020;17:395–417.

[10] ChenD, FanZ, RauhM et al. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner. Oncogene 2017;36:5593–5608.

[11] ChenL, ZhangZ, HoshinoA et al. NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism. Nat Metab 2019;1:404–415.

[12] ChenX, YuC, KangR et al. Iron metabolism in ferroptosis. Front Cell Dev Biol 2020;8:590226.

[13] ChenD, ChuB, YangX et al. iPLA2beta-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4. Nat Commun 2021a;12:3644.

[14] ChenSY, ChangYL, LiuST et al. Differential cytotoxicity mechanisms of copper complexed with disulfiram in oral cancer cells. Int J Mol Sci 2021b;22:3711.

[15] ChenX, ComishPB, TangD et al. Characteristics and biomarkers of ferroptosis. Front Cell Dev Biol 2021c;9:637162.

[16] ChenX, KangR, KroemerG et al. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol 2021d;18:280–296.

[17] ChenL, MinJ, WangF. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther 2022;7:378.

[18] ChimientiF, SeveM, RichardS et al. Role of cellular zinc in programmed cell death: temporal relationship between zinc depletion, activation of caspases, and cleavage of Sp family transcription factors. Biochem Pharmacol 2001;62:51–62.

[19] CobinePA, MooreSA, LearySC. Getting out what you put in: copper in mitochondria and its impacts on human disease. Biochim Biophys Acta Mol Cell Res 2021;1868:118867.

[20] ConradM, PrattDA. The chemical basis of ferroptosis. Nat Chem Biol 2019;15:1137–1147.

[21] CramerSL, SahaA, LiuJ et al. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nat Med 2017;23:120–127.

[22] de BieP, MullerP, WijmengaC et al. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet 2007;44:673–688.

[23] DeshwalS, OnishiM, TatsutaT et al. Mitochondria regulate intracellular coenzyme Q transport and ferroptotic resistance via STARD7. Nat Cell Biol 2023;25:246–257.

[24] DevinneyMJ, Malaiyandi LM, VergunO et al. A comparison of Zn²⁺- and Ca²⁺-triggered depolarization of liver mitochondria reveals no evidence of Zn²⁺-induced permeability transition. Cell Calcium 2009;45:447–455.

[25] DixonSJ, Lemberg KM, LamprechtMR et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 2012;149:1060–1072.

[26] DixonSJ, PatelDN, WelschM et al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife 2014;3:e02523.

[27] DixonSJ, WinterGE, MusaviLS et al. Human haploid cell genetics reveals roles for lipid metabolism genes in non-apoptotic cell death. ACS Chem Biol 2015;10:1604–1609.

[28] DollS, Proneth B, TyurinaYY et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 2017;13:91–98.

[29] DollS, Freitas FP, ShahR et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 2019;575:693–698.

[30] DreishpoonMB, BickNR, PetrovaB et al. FDX1 regulates cellular protein lipoylation through direct binding to LIAS. J Biol Chem 2023;299:105046.

[31] DuW, GuM, HuM et al. Lysosomal Zn(2+) release triggers rapid, mitochondria-mediated, non-apoptotic cell death in metastatic melanoma. Cell Rep 2021;37:109848.

[32] EatonJK, FurstL, RubertoRA et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat Chem Biol 2020;16:497–506.

[33] FengH, Stockwell BR. Unsolved mysteries: how does lipid peroxidation cause ferroptosis? PLoS Biol 2018;16:e2006203.

[34] FengH, Schorpp K, JinJ et al. Transferrin receptor is a specific ferroptosis marker. Cell Rep 2020;30:3411–3423.e7.

[35] Friedmann AngeliJP, Schneider M, PronethB et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 2014;16:1180–1191.

[36] GalluzziL, VitaleI, AaronsonSA et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 2018;25:486–541.

[37] GanB. Mitochondrial regulation of ferroptosis. J Cell Biol 2021;220:e202105043.

[38] GanY, LiuT, FengW et al. Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways. Oncol Res 2023;31:333–343.

[39] GaoM, MonianP, PanQ et al. Ferroptosis is an autophagic cell death process. Cell Res 2016;26:1021–1032.

[40] GaoM, YiJ, ZhuJ et al. Role of mitochondria in ferroptosis. Mol Cell 2019;73:354–363.e3.

[41] GaoR, Kalathur RKR, Coto-LlerenaM et al. YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis. EMBO Mol Med 2021;13:e14351.

[42] GeEJ, BushAI, CasiniA et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer 2022;22:102–113.

[43] GojiT, Takahara K, NegishiM et al. Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation. J Biol Chem 2017;292:19721–19732.

[44] GreenDR, VictorB. The pantheon of the fallen: why are there so many forms of cell death? Trends Cell Biol 2012;22:555–556.

[45] GuerraRM, Pagliarini DJ. Coenzyme Q biochemistry and biosynthesis. Trends Biochem Sci 2023;48:463–476.

[46] GurunathanS, KangMH, QasimM et al. Biogenesis, membrane trafficking, functions, and next generation nanotherapeutics medicine of extracellular vesicles. Int J Nanomedicine 2021;16:3357–3383.

[47] HadianK, Stockwell BR. The therapeutic potential of targeting regulated non-apoptotic cell death. Nat Rev Drug Discov 2023;22:723–742.

[48] HangauerMJ, Viswanathan VS, RyanMJ et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 2017;551:247–250.

[49] HarayamaT, Riezman H. Understanding the diversity of membrane lipid composition. Nat Rev Mol Cell Biol 2018;19:281–296.

[50] HarayamaT, Shimizu T. Roles of polyunsaturated fatty acids, from mediators to membranes. J Lipid Res 2020;61:1150–1160.

[51] HasanNM, GuptaA, PolishchukE et al. Molecular events initiating exit of a copper-transporting ATPase ATP7B from the trans-Golgi network. J Biol Chem 2012;287:36041–36050.

[52] HatoriY, Lutsenko S. The role of Copper Chaperone Atox1 in coupling redox homeostasis to intracellular copper distribution. Antioxidants (Basel) 2016;5:25.

[53] HedleyD, Shamas-Din A, ChowS et al. A phase I study of elesclomol sodium in patients with acute myeloid leukemia. Leuk Lymphoma 2016;57:2437–2440.

[54] HotchkissRS, Strasser A, McDunnJE et al. Cell death. N Engl J Med 2009;361:1570–1583.

[55] HouW, XieY, SongX et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy 2016;12:1425–1428.

[56] HuangJ, Campian JL, GujarAD et al. A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy. J Neurooncol 2016;128:259–266.

[57] IngoldI, BerndtC, SchmittS et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell 2018;172:409–422.e21.

[58] JantasD, Chwastek J, GrygierB et al. Neuroprotective effects of necrostatin-1 against oxidative stress-induced cell damage: an involvement of Cathepsin D inhibition. Neurotox Res 2020;37:525–542.

[59] JiangL, KonN, LiT et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature 2015;520:57–62.

[60] JiangX, Stockwell BR, ConradM. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 2021;22:266–282.

[61] JolyJH, Delfarah A, PhungPS et al. A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose. J Biol Chem 2020;295:1350–1365.

[62] KimR, Hashimoto A, MarkosyanN et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature 2022;612:338–346.

[63] KoppulaP, ZhangY, ShiJ et al. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate. J Biol Chem 2017;292:14240–14249.

[64] KoppulaP, ZhangY, ZhuangL et al. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond) 2018;38:12.

[65] KoppulaP, Olszewski K, ZhangY et al. KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition. iScience 2021a;24:102649.

[66] KoppulaP, ZhuangL, GanB. Cystine transporter SLC7A11/ xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 2021b;12:599–620.

[67] KoppulaP, LeiG, ZhangY et al. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun 2022;13:2206.

[68] KorenE, FuchsY. Modes of regulated cell death in cancer. Cancer Discov 2021;11:245–265.

[69] KraftVAN, Bezjian CT, PfeifferS et al. GTP Cyclohydrolase 1/Tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci 2020;6:41–53.

[70] KuoYM, ZhouB, CoscoD et al. The copper transporter CTR1 provides an essential function in mammalian embryonic development. Proc Natl Acad Sci USA 2001;98:6836–6841.

[71] KuoMT, FuS, SavarajN et al. Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy. Cancer Res 2012;72:4616–4621.

[72] Lagadic-GossmannD, Huc L, LecureurV. Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ 2004;11:953–961.

[73] LangX, GreenMD, WangW et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov 2019;9:1673–1685.

[74] LeakL, DixonSJ. Surveying the landscape of emerging and understudied cell death mechanisms. Biochim Biophys Acta Mol Cell Res 2023;1870:119432.

[75] LeeJM, LeeH, KangS et al. Fatty acid desaturases, polyunsaturated fatty acid regulation, and biotechnological advances. Nutrients 2016;8:23.

[76] LeeH, Zandkarimi F, ZhangY et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol 2020;22:225–234.

[77] LeiG, ZhangY, KoppulaP et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res 2020;30:146–162.

[78] LeiG, ZhangY, HongT et al. Ferroptosis as a mechanism to mediate p53 function in tumor radiosensitivity. Oncogene 2021;40:3533–3547.

[79] LeiG, ZhuangL, GanB. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer 2022;22:381–396.

[80] LiH, WangJ, WuC et al. The combination of disulfiram and copper for cancer treatment. Drug Discov Today 2020;25:1099–1108.

[81] LiZ, Ferguson L, DeolKK et al. Ribosome stalling during selenoprotein translation exposes a ferroptosis vulnerability. Nat Chem Biol 2022;18:751–761.

[82] LiangD, Minikes AM, JiangX. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell 2022;82:2215–2227.

[83] LiangD, FengY, ZandkarimiF et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell 2023;186:2748–2764.e22.

[84] LiaoP, WangW, WangW et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 2022;40:365–378.e6.

[85] LinC, ZhangZ, WangT et al. Copper uptake by DMT1: a compensatory mechanism for CTR1 deficiency in human umbilical vein endothelial cells. Metallomics 2015;7:1285–1289.

[86] LiuY, GuW. p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death Differ 2022;29:895–910.

[87] LiuT, JiangL, TavanaO et al. The Deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11. Cancer Res 2019;79:1913–1924.

[88] LiuJ, KuangF, KangR et al. Alkaliptosis: a new weapon for cancer therapy. Cancer Gene Ther 2020a;27:267–269.

[89] LiuX, Olszewski K, ZhangY et al. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol 2020b;22:476–486.

[90] LiuX, ZhangY, ZhuangL et al. NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation. Genes Dis 2021;8:731–745.

[91] LiuX, NieL, ZhangY et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol 2023;25:404–414.

[92] LiuX, ZhuangL, GanB. Disulfidptosis: disulfide stress-induced cell death. Trends Cell Biol 2024;34:327–337.

[93] LuisG, Godfroid A, NishiumiS et al. Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biol 2021;43:102006.

[94] LushchakVI. Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids 2012;2012:736837.

[95] MagtanongL, KoPJ, ToM et al. Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell Chem Biol 2019;26:420–432.e9.

[96] MagtanongL, Mueller GD, WilliamsKJ et al. Context-dependent regulation of ferroptosis sensitivity. Cell Chem Biol 2022;29:1409–1418.e6.

[97] MaoC, LiuX, ZhangY et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature 2021;593:586–590.

[98] MaoC, LiuX, YanY et al. Reply to: DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition. Nature 2023;619:E19–E23.

[99] MishimaE, ItoJ, WuZ et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature 2022;608:778–783.

[100] MishimaE, Nakamura T, ZhengJ et al. DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition. Nature 2023;619:E9–E18.

[101] NagaiM, VoNH, Shin OgawaL et al. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells. Free Radic Biol Med 2012;52:2142–2150.

[102] NakamuraE, SatoM, YangH et al. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem 1999;274:3009–3016.

[103] NakamuraT, HippC, Santos Dias MouraoA et al. Phase separation of FSP1 promotes ferroptosis. Nature 2023;619:371–377.

[104] O’DayS, Gonzalez R, LawsonD et al. Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma. J Clin Oncol 2009;27:5452–5458.

[105] O’DaySJ, Eggermont AM, Chiarion-SileniV et al. Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma. J Clin Oncol 2013;31:1211–1218.

[106] PalumaaP, KangurL, VoronovaA et al. Metal-binding mechanism of Cox17, a copper chaperone for cytochrome c oxidase. Biochem J 2004;382:307–314.

[107] PavlovaNN, ZhuJ, ThompsonCB. The hallmarks of cancer metabolism: still emerging. Cell Metab 2022;34:355–377.

[108] ReedA, IchuTA, MilosevichN et al. LPCAT3 inhibitors remodel the polyunsaturated phospholipid content of human cells and protect from Ferroptosis. ACS Chem Biol 2022;17:1607–1618.

[109] Rojo de la VegaM, Chapman E, ZhangDD. NRF2 and the hallmarks of cancer. Cancer Cell 2018;34:21–43.

[110] RowlandEA, Snowden CK, CristeaIM. Protein lipoylation: an evolutionarily conserved metabolic regulator of health and disease. Curr Opin Chem Biol 2018;42:76–85.

[111] RoyerA, Sharman T. Copper toxicity. Treasure Island, FL: StatPearls, 2023.

[112] SasakiH, SatoH, Kuriyama-MatsumuraK et al. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem 2002;277:44765–44771.

[113] SatoH, TambaM, IshiiT et al. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem 1999;274:11455–11458.

[114] SatoH, NomuraS, MaebaraK et al. Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation. Biochem Biophys Res Commun 2004;325:109–116.

[115] SchmidtK, RalleM, SchafferT et al. ATP7A and ATP7B copper transporters have distinct functions in the regulation of neuronal dopamine-beta-hydroxylase. J Biol Chem 2018;293:20085–20098.

[116] ShahR, Shchepinov MS, PrattDA. Resolving the role of lipoxygenases in the initiation and execution of ferroptosis. ACS Cent Sci 2018;4:387–396.

[117] ShimadaK, ReznikE, StokesME et al. Copper-binding small molecule induces oxidative stress and cell-cycle arrest in glioblastoma-patient-derived cells. Cell Chem Biol 2018;25:585–594.e7.

[118] ShinCS, MishraP, WatrousJD et al. The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility. Nat Commun 2017;8:15074.

[119] SongX, ZhuS, ChenP et al. AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking system Xc(-) activity. Curr Biol 2018a;28:2388–2399.e5.

[120] SongX, ZhuS, XieY et al. JTC801 induces pH-dependent death specifically in cancer cells and slows growth of tumors in mice. Gastroenterology 2018b;154:1480–1493.

[121] SoulaM, WeberRA, ZilkaO et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat Chem Biol 2020;16:1351–1360.

[122] SuZ, KonN, YiJ et al. Specific regulation of BACH1 by the hotspot mutant p53(R175H) reveals a distinct gain-of-function mechanism. Nat Cancer 2023;4:564–581.

[123] SunX, OuZ, ChenR et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 2016;63:173–184.

[124] SwietachP, PatiarS, SupuranCT et al. The role of carbonic anhydrase 9 in regulating extracellular and intracellular ph in three-dimensional tumor cell growths. J Biol Chem 2009;284:20299–20310.

[125] TangD, KangR, BergheTV et al. The molecular machinery of regulated cell death. Cell Res 2019;29:347–364.

[126] TangT, YangZY, WangD et al. The role of lysosomes in cancer development and progression. Cell Biosci 2020;10:131.

[127] TangD, Kroemer G, KangR. Ferroptosis in immunostimulation and immunosuppression. Immunol Rev 2023;321:199–210.

[128] TapiaL, Gonzalez-Aguero M, CisternasMF et al. Metallothionein is crucial for safe intracellular copper storage and cell survival at normal and supra-physiological exposure levels. Biochem J 2004;378:617–624.

[129] TarangeloA, Magtanong L, Bieging-RolettKT et al. p53 Suppresses metabolic stress-induced ferroptosis in cancer cells. Cell Rep 2018;22:569–575.

[130] TriscottJ, LeeC, HuK et al. Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide. Oncotarget 2012;3:1112–1123.

[131] TsvetkovP, Detappe A, CaiK et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat Chem Biol 2019;15:681–689.

[132] TsvetkovP, CoyS, PetrovaB et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 2022;375:1254–1261.

[133] TummersB, GreenDR. Caspase-8: regulating life and death. Immunol Rev 2017;277:76–89.

[134] UrsiniF, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med 2020;152:175–185.

[135] VandenabeeleP, Bultynck G, SavvidesSN. Pore-forming proteins as drivers of membrane permeabilization in cell death pathways. Nat Rev Mol Cell Biol 2023;24:312–333.

[136] VeverkaKA, Johnson KL, MaysDC et al. Inhibition of aldehyde dehydrogenase by disulfiram and its metabolite methyl diethylthiocarbamoyl-sulfoxide. Biochem Pharmacol 1997;53:511–518.

[137] ViswanathanVS, RyanMJ, DhruvHD et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 2017;547:453–457.

[138] VogtAS, Arsiwala T, MohsenM et al. On iron metabolism and its regulation. Int J Mol Sci 2021;22:4591.

[139] WangYZ, WangJJ, HuangY et al. Tissue acidosis induces neuronal necroptosis via ASIC1a channel independent of its ionic conduction. Elife 2015;4:e05682.

[140] WangW, GreenM, ChoiJE et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 2019;569:270–274.

[141] WangME, ChenJ, LuY et al. RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis. J Clin Invest 2023a;133:e166647.

[142] WangZ, OuyangL, LiuN et al. The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis. Oncogene 2023b;42:2688–2700.

[143] WeaverK, SkoutaR. The Selenoprotein Glutathione Peroxidase 4: from molecular mechanisms to novel therapeutic opportunities. Biomedicines 2022;10:891.

[144] WhiteKA, Grillo-Hill BK, BarberDL. Cancer cell behaviors mediated by dysregulated pH dynamics at a glance. J Cell Sci 2017;130:663–669.

[145] WrightGSA. Molecular and pharmacological chaperones for SOD1. Biochem Soc Trans 2020;48:1795–1806.

[146] WuJ, Minikes AM, GaoM et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature 2019;572:402–406.

[147] WuS, MaoC, KondiparthiL et al. A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria. Proc Natl Acad Sci U S A 2022;119:e2121987119.

[148] WuK, YanM, LiuT et al. Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function. Nat Cell Biol 2023;25:714–725.

[149] XieY, ZhuS, SongX et al. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep 2017;20:1692–1704.

[150] XuT, SuH, GanapathyS et al. Modulation of autophagic activity by extracellular pH. Autophagy 2011;7:1316–1322.

[151] XuH, YeD, RenM et al. Ferroptosis in the tumor microenvironment: perspectives for immunotherapy. Trends Mol Med 2021;27:856–867.

[152] YamaguchiS, MiuraC, KikuchiK et al. Zinc is an essential trace element for spermatogenesis. Proc Natl Acad Sci U S A 2009;106:10859–10864.

[153] YanB, AiY, SunQ et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell 2021;81:355–369.e10.

[154] YanY, TengH, HangQ et al. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nat Commun 2023;14:3673.

[155] YangWS, SriRamaratnam R, WelschME et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 2014;156:317–331.

[156] YangWS, KimKJ, GaschlerMM et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci USA 2016;113:E4966–E4975.

[157] YangWH, DingCC, SunT et al. The Hippo Pathway Effector TAZ regulates ferroptosis in renal cell carcinoma. Cell Rep 2019;28:2501–2508.e4.

[158] YangC, ZhaoY, WangL et al. De novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defence. Nat Cell Biol 2023a;25:836–847.

[159] YangX, WangZ, ZandkarimiF et al. Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism. Cell Metab 2023b;35:1474–1490. e8.

[160] YantLJ, RanQ, RaoL et al. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic Biol Med 2003;34:496–502.

[161] YeLF, Chaudhary KR, ZandkarimiF et al. Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers. ACS Chem Biol 2020;15:469–484.

[162] YiJ, ZhuJ, WuJ et al. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A 2020;117:31189–31197.

[163] YuX, Vazquez A, LevineAJ et al. Allele-specific p53 mutant reactivation. Cancer Cell 2012;21:614–625.

[164] YuanH, LiX, ZhangX et al. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun 2016;478:1338–1343.

[165] ZhanM, DingY, HuangS et al. Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase. Nat Commun 2023;14:3123.

[166] ZhangY, ShiJ, LiuX et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol 2018;20:1181–1192.

[167] ZhangY, SwandaRV, NieL et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun 2021;12:1589.

[168] ZhangHL, HuBX, LiZL et al. PKCbetaII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis. Nat Cell Biol 2022;24:88–98.

[169] ZhengJ, SatoM, MishimaE et al. Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines. Cell Death Dis 2021;12:698.

[170] ZhengP, ZhouC, LuL et al. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. J Exp Clin Cancer Res 2022;41:271.

[171] ZhongZ, ZhangC, NiS et al. NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors. Redox Biol 2023;63:102711.

[172] ZhuS, LiuJ, KangR et al. Targeting NF-kappaB-dependent alkaliptosis for the treatment of venetoclax-resistant acute myeloid leukemia cells. Biochem Biophys Res Commun 2021;562:55–61.

[173] ZouY, LiH, GrahamET et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol 2020;16:302–309.

RIGHTS & PERMISSIONS

The Author(s) 2024. Published by Oxford University Press on behalf of Higher Education Press.